Article info
Airway biology
Original article
EP4 receptor as a new target for bronchodilator therapy
- Correspondence to Professor Maria G Belvisi, Respiratory Pharmacology, Pharmacology and Toxicology Section, Imperial College London, Faculty of Medicine, National Heart and Lung Institute, Sir Alexander Fleming Building, London SW7 2AZ, UK; m.belvisi{at}imperial.ac.uk
Citation
EP4 receptor as a new target for bronchodilator therapy
Publication history
- Received December 30, 2010
- Accepted April 6, 2011
- First published May 23, 2011.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 July 2016).
- You are viewing the most recent version of this article.
Web Only Data thx.2010.158568
Files in this Data Supplement:
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.